Watch the latest episode of focusIR Fireside Chats: Why Edinburgh Investment Trust Is Backing Turnaround Stocks for 2026 Growth. View here

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksTiton Regulatory News (TON)

Share Price Information for Titon (TON)

Share Price is delayed by 15 minutes
Get Live Data
80.00    0.00 (0.00%)
Bid:
75.00
Ask:
85.00
Spread: 10.00 (13.333%)
Market Cap: £9.00m
TON Live PriceLast checked at - London Stock Exchange

Intraday Titon Share Chart

Hardman & Co Research: Electiton

17 Dec 2019 07:30

Hardman & Co Research Hardman & Co Research: Electiton 17-Dec-2019 / 07:30 GMT/BST


Hardman & Co Research: Electiton

'Tis rare that a company reports on the same day as a general election. Okay, Titon's gestation was the longer but the conclusions are the same. "It's over and yet it has only just begun". For Boris Johnson, this means actually 'getting Brexit done' and running the country. For Titon, it has just reported its full year in which it coped manfully with a number of travails; and now has to do the same in the next one and 'win the peace'. Boris's skill-set to deal with in-coming remains the subject of speculation. Not so Titon's.

https://www.hardmanandco.com/research/corporate-research/electiton/

 

To contact us:

Hardman & Co35 New Broad StreetLondonEC2M 1NH

www.hardmanandco.com

Follow us on Twitter @HardmanandCo

Contacts:

Tony Williams 

+44 20 7194 7622

 

research@hardmanandco.com

 

Hardman & Co Research can still be accessed for free after MiFID II. Please click here to read the statement.

About Hardman & Co: For the past 21 years Hardman has been producing specialist research designed to improve investors' understanding of companies, sectors, industries and investment securities. Our analysts are highly experienced in their sectors, and have often been highly rated by professional investors for their knowledge. Our focus is to raise companies' profiles across the UK and abroad with outstanding research, investor engagement programmes and advisory services. Some of our notes have been commissioned by the company which is the subject of the note; this is clearly stated in the disclaimer where this is the case.

Hardman Research Ltd, trading as Hardman & Co, is an appointed representative of Capital Markets Strategy Ltd and is authorised and regulated by the Financial Conduct Authority; our FCA registration number is 600843. Hardman Research Ltd is registered at Companies House with number 8256259.

Our research is provided for the use of the professional investment community, market counterparties and sophisticated and high net worth investors as defined in the rules of the regulatory bodies. It is not intended to be made available to unsophisticated retail investors. Anyone who is unsure of their categorisation should consult their professional advisors. This research is neither an offer, nor a solicitation, to buy or sell any security. Please read the note for the full disclaimer.

 


Dissemination of a CORPORATE NEWS, transmitted by EQS Group.The issuer is solely responsible for the content of this announcement.


End of Announcement - EQS News Service

937487 17-Dec-2019 

corporate announcement transmitted by DGAP - a service of EQS Group AG. The issuer is solely responsible for the content of this announcement.

Date   Source Headline
29th Jun 202311:30 amRNSNotification of Major Holdings
28th Jun 20232:00 pmRNSNotification of Major Holdings
6th Jun 20231:40 pmRNSNotification of major holdings
6th Jun 20237:00 amRNSNotification of major holdings
1st Jun 20232:07 pmRNSHolding(s) in Company
31st May 20235:38 pmRNSDirector shareholding
23rd May 202310:20 amRNSAmendment to dividend timetable in interim results
19th May 20237:00 amRNSInterim results for the six months to 31 Mar 2023
18th Apr 20236:10 pmRNSHolding(s) in Company
14th Apr 202312:52 pmRNSIssue of Equity
12th Apr 20235:15 pmRNSNotification of major holdings
11th Apr 20233:40 pmRNSNotification of major holdings
6th Apr 20236:03 pmRNSResignation of Chief Executive Officer
6th Apr 20234:36 pmRNSNotification of Major Holdings
22nd Mar 20234:30 pmRNSResult of AGM
22nd Mar 20237:00 amRNSTrading Update
24th Feb 20239:30 amRNSAnnual Report & AGM notice
26th Jan 20237:11 amRNSAnnual Report & Financial Statements
29th Nov 20227:00 amRNSTrading Update
7th Oct 20223:30 pmRNSNotification of Major Holdings
15th Sep 202211:01 amRNSChange of Board role
6th Sep 20224:30 pmRNSChange of Auditor
10th Aug 20225:15 pmRNSExercise of options and Director/PDMR Shareholding
3rd Aug 20223:00 pmRNSDirector/PDMR Shareholding
22nd Jul 20223:45 pmRNSDirector/PDMR Shareholding
22nd Jul 20227:00 amRNSTrading Update
29th Jun 20225:29 pmRNSGrant of Options and Director/PDMR Shareholding
28th Jun 20223:20 pmRNSHolding(s) in Company
6th Jun 20223:15 pmRNSHolding(s) in Company Update
6th Jun 20223:15 pmRNSHolding(s) in Company Update
12th May 20227:00 amRNSInterim Results for six months to 31 March 2022
22nd Apr 20227:00 amRNSAppointment of CEO
1st Apr 20227:00 amRNSNon-Executive Director and Board changes
23rd Feb 20226:08 pmRNSResult of AGM
22nd Feb 20227:00 amRNSTrading Update
7th Feb 20223:00 pmRNSDirectorate Change
20th Jan 202212:15 pmRNS2021 Annual Report and Notice of AGM
22nd Dec 20217:00 amRNSAppointment of CFO
21st Dec 20217:00 amRNSPreliminary Announcement results year to 30/09/21
14th Dec 20215:22 pmRNSRevised preliminary results announcement date
12th Nov 20214:30 pmRNSDirector/PDMR Shareholding
10th Nov 202112:21 pmRNSChief Executive Officer resignation
24th Sep 20212:11 pmRNSDirector/PDMR Shareholding
9th Sep 20217:00 amRNSDirectorate Change
23rd Jul 202111:15 amRNSDirector/PDMR Shareholding
13th May 20217:00 amRNSUnaudited Interim Results to 31 March 2021
24th Mar 20217:00 amRNSAppointment of CEO
10th Mar 20214:45 pmRNSResult of AGM and Trading Statement
11th Feb 20219:30 amRNS2020 Annual Report and Notice of 2021 AGM
26th Jan 202110:35 amRNSExercise of options and Director/PDMR shareholding

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.